Biblio

Found 10 results
Filters: Keyword is Rats  [Clear All Filters]
2011
V. Sharma, Sharma, A., Saran, V., Bernatchez, P. N., Allard, M. F., and McNeill, J. H., “β-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions.”, Eur J Pharmacol, vol. 657, no. 1-3, pp. 117-25, 2011.
2010
V. Sharma, Abraham, T., So, A., Allard, M. F., and McNeill, J. H., “Functional effects of protein kinases and peroxynitrite on cardiac carnitine palmitoyltransferase-1 in isolated mitochondria.”, Mol Cell Biochem, vol. 337, no. 1-2, pp. 223-37, 2010.
2009
R. Saeedi, Saran, V. V., S Y Wu, S., Kume, E. S., Paulson, K., Chan, A. P. K., Parsons, H. L., Wambolt, R. B., Dyck, J. R. B., Brownsey, R. W., and Allard, M. F., “AMP-activated protein kinase influences metabolic remodeling in H9c2 cells hypertrophied by arginine vasopressin.”, Am J Physiol Heart Circ Physiol, vol. 296, no. 6, pp. H1822-32, 2009.
H. Y. Choi, Rahmani, M., Wong, B. W., Allahverdian, S., McManus, B. M., J Pickering, G., Chan, T., and Francis, G. A., “ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells.”, Circulation, vol. 119, no. 25, pp. 3223-31, 2009.
K. D. Folmes, Chan, A. Y. M., P Y Koonen, D., Pulinilkunnil, T. C., Baczkó, I., Hunter, B. E., Thorn, S., Allard, M. F., Roberts, R., Gollob, M. H., Light, P. E., and Dyck, J. R. B., “Distinct early signaling events resulting from the expression of the PRKAG2 R302Q mutant of AMPK contribute to increased myocardial glycogen.”, Circ Cardiovasc Genet, vol. 2, no. 5, pp. 457-66, 2009.
V. Sharma, Mustafa, S., Patel, N., Wambolt, R., Allard, M. F., and McNeill, J. H., “Stimulation of cardiac fatty acid oxidation by leptin is mediated by a nitric oxide-p38 MAPK-dependent mechanism.”, Eur J Pharmacol, vol. 617, no. 1-3, pp. 113-7, 2009.
2008
A. L. Hunter, Kerjner, A., Mueller, K. J., McManus, B. M., and Granville, D. J., “Cytochrome p450 2C enzymes contribute to peritransplant ischemic injury and cardiac allograft vasculopathy.”, Am J Transplant, vol. 8, no. 8, pp. 1631-8, 2008.
J. H. Boyd, Chau, E. H., Tokunanga, C., Bateman, R. M., Haljan, G., Davani, E. Y., Wang, Y., and Walley, K. R., “Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism.”, Crit Care, vol. 12, no. 1, p. R2, 2008.
2004
J. C. Choy, H Y Hung, V., Hunter, A. L., Cheung, P. K., Motyka, B., Goping, I. Swie, Sawchuk, T., R Bleackley, C., Podor, T. J., McManus, B. M., and Granville, D. J., “Granzyme B induces smooth muscle cell apoptosis in the absence of perforin: involvement of extracellular matrix degradation.”, Arterioscler Thromb Vasc Biol, vol. 24, no. 12, pp. 2245-50, 2004.
D. J. Granville, Tashakkor, B., Takeuchi, C., Gustafsson, A. B., Huang, C., M Sayen, R., Wentworth, P., Yeager, M., and Gottlieb, R. A., “Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors.”, Proc Natl Acad Sci U S A, vol. 101, no. 5, pp. 1321-6, 2004.